Nicholas A. Saccomano

Chief Scientific Officer at Array BioPharma Inc.

Nicholas A. Saccomano

Nicholas A. Saccomano

Chief Scientific Officer at Array BioPharma Inc.

Overview
RelSci Relationships

4093

Number of Boards

7

Birthday

1959

Age

60

Contact Data
Trying to get in touch with Nicholas A. Saccomano? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Nicholas A. Saccomano likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Chromis Therapeutics, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Bend Research, Inc.

Relationship likelihood: Strong

Associate Vice President & Executive Director of the Innovation & New Venture Office at Northwestern University

Relationship likelihood: Strong

Professor at North Carolina State University

Relationship likelihood: Strong

Regulatory Compliance & Product Development Consultant at FluTrends International Corp.

Relationship likelihood: Strong

Chief Financial & Accounting Officer at Clovis Oncology, Inc.

Relationship likelihood: Strong

Executive Director, Communications at SomaLogic, Inc.

Relationship likelihood: Strong

Co-Founder at Evolutionary Genomics, Inc.

Relationship likelihood: Strong

Executive Vice President & Chief Financial Officer at Cutera, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Chief Financial Officer & Secretary at Afraxis, Inc.

Relationship likelihood: Strong

Paths to Nicholas A. Saccomano
Potential Connections via
Relationship Science
You
Nicholas A. Saccomano
Chief Scientific Officer at Array BioPharma Inc.
Education
Ph.D. in Synthetic Organic Chemistry
Class of 1984

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

B.S. in Chemistry
Class of 1980

The State University of New York is the largest comprehensive university system in the United States, educating approximately 468,000 students in more than 7,500 degree and certificate programs, and more than 1.8 million NYS citizens in professional development and personal enrichment programs, on 64 college and university campuses. There are nearly 3 million SUNY alumni worldwide.

B.S Chemistry
Class of 1980

University at Buffalo, The State University of New York, also commonly known as the University of Buffalo (abbreviated UB), University of Buffalo or SUNY Buffalo, is a public research university with multiple campuses located in Buffalo and Amherst, New York, United States. The university was founded in 1846 as a private college, but in 1962 was absorbed into the State University of New York (SUNY) system. By enrollment, UB is the largest of SUNY's four comprehensive university centers, and also the largest public university in the northeastern United States (comprising New York state and the New England region). In addition, by either endowment or research funding, UB is also the largest one of SUNY's four comprehensive flagship university centers.

Career History
Chief Scientific Officer
2014 - Current

Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Chief Technology Officer
2009 - 2014

SomaLogic, Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at your institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.

Chief Scientific Officer
2008 - 2008

Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.

Boards & Committees
Member, Board of Directors
2008 - Current

Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.

Board Member
Current
Member, Advisory Board
Current

Torrey Pines Investment focuses on investments in the biotechnology and pharmaceutical sectors.

Member, Board of Directors
Current

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. In 1853 the founders purchased a 379-acre tract of land on the shore of Lake Michigan 12 miles north of Chicago. They established a campus and developed the land near it, naming the surrounding town Evanston in honor of one of the University's founders, John Evans. After completing its first building, its first building in 1855, Northwestern began classes that fall with two faculty members and 10 students. Northwestern has three campuses and a total of 12 Schools and Colleges (one of which is located in South Florida. Two campuses are located on Lake Michigan, a 240-acre campus in Evanston, the first suburb north of Chicago, and a 25-acre campus in Chicago. One campus is located in Doha, Qatar. Northwestern University combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. It provides students and faculty exceptional opportunities for intellectual, personal and professional growth in a setting enhanced by the richness of Chicago.

Transactions
Details Hidden

SomaLogic, Inc. raised money in a private placement transaction

Details Hidden

SomaLogic, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nicholas A. Saccomano. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nicholas A. Saccomano's profile does not indicate a business or promotional relationship of any kind between RelSci and Nicholas A. Saccomano.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://news.relsci.com/person/nicholas-a-saccomano-4358369
  • https://news.relsci.com/person/nicholas-a-saccomano-4358369